SB-735216

ID: ALA3988876

Chembl Id: CHEMBL3988876

PubChem CID: 86064664

Max Phase: Preclinical

Molecular Formula: C13H12N4

Molecular Weight: 224.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1c(-c2ccncc2)nc2cnccc21

Standard InChI:  InChI=1S/C13H12N4/c1-2-17-12-5-8-15-9-11(12)16-13(17)10-3-6-14-7-4-10/h3-9H,2H2,1H3

Standard InChI Key:  WBPBRVGKZKRPSZ-UHFFFAOYSA-N

Alternative Forms

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 224.27Molecular Weight (Monoisotopic): 224.1062AlogP: 2.51#Rotatable Bonds: 2
Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.18CX LogP: 1.43CX LogD: 1.43
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.67Np Likeness Score: -1.47

References

1. Simon Townson and Suzanne Gokool. GlaxoSmithKline Published Kinase Inhibitor Set 2 Onchocerca lienalis Screening Data,  [10.6019/CHEMBL3988181]